Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Burning Rock Pan-canceR Early DetectIon projeCT (PREDICT): a Prospective, Multicenter Study to Develop and Validate the Performance of a cfDNA Methylation Based Model on Early Cancer Detection

NCT04383353 is registered in ClinicalTrials.gov with Guangzhou Burning Rock Dx Co., Ltd. as lead sponsor.

NCT NCT04383353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04383353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Burning Rock Pan-canceR Early DetectIon projeCT (PREDICT): a Prospective, Multicenter Study to Develop and Validate the Performance of a cfDNA Methylation Based Model on Early Cancer Detection
Lead sponsor
Guangzhou Burning Rock Dx Co., Ltd.
Phase
Observational
Overall status
Unknown status
Start date
July 21, 2020
Completion date
March 31, 2023
Enrollment
14,026 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cancer